The new generation of B cell-targeting therapies for the treatment of autoimmune kidney diseases

Nephrol Dial Transplant. 2024 Jul 31;39(8):1210-1213. doi: 10.1093/ndt/gfad265.

Authors

Giorgio Trivioli¹, Francesco Peyronel^{2

3}, Augusto Vaglio^{3

4}

Affiliations

¹ Department of Nephrology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.
² Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
³ Nephrology and Dialysis Unit, Meyer Children's Hospital IRCCS, Firenze, Italy.
⁴ Department of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Firenze, Firenze, Italy.

PMID: 38111254
DOI: 10.1093/ndt/gfad265

No abstract available

Publication types

Editorial

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use
Autoimmune Diseases* / immunology
Autoimmune Diseases* / therapy
B-Lymphocytes* / immunology
Humans
Kidney Diseases* / therapy

Substances

Antibodies, Monoclonal